Abstract
The recent development of symptomatic pharmacological treatment for Alzheimer’s disease (AD) and the probable introduction of new therapies in a near future make the assessment of dementia at its different stages an even greater scientific and public health challenge. Neuropsychological tests, together with clinical data, are at present the only in vivo non-invasive screening and diagnostic tools for AD and related disorders. This chapter reviews the application to AD of standard batteries and short screening tests. It also analyzes the tests to be applied to detect and assess the specific deficits of the disease, and discusses the advantages and flaws of current screening and diagnostic tests of dementia. Emphasis is placed on the need to devise and use tests developed in a rational manner, with high sensitivity and specificity, not only in the moderate stages of the disease, but also in the very early and even “preclinical” stages, as well as during the late stages (severe dementia). It is known that neuropsychological tests allow one to determine various patients’ profiles. Future research should determine the possible predictive value of these profiles. This has important implications for therapeutic trials. The current implicit assumption that all patients with AD tend to evolve and decline in a similar fashion needs to be critically re-examined.
Similar content being viewed by others
References
American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed. 4th. American Psychiatric Association, Washington, DC, 1994.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M.: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944, 1984.
Folstein M.F., Folstein S.E., McHugh P.R.: “Mini Mental State”: A practical method for grading the cognitive state of patients for the clinicians. J. Psychiatr. Res. 12: 189–198, 1975.
Grut M., Fratiglioni L., Viitanen M., Winblad B.: Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol. Scand. 87: 312–317, 1993.
Binet A.: Etude expérimentale de l’Intelligence. Paris, 1903.
Wechsler D.: The measurement of adult intelligence. Williams and Wilkins, Baltimore, 1939.
Russell E.: WAIS factor analysis with brain-damaged subjects using criterion measures. J. Cons. Clin. Psychol. 39: 133–139, 1972.
Lezak M.D.: Neuropsychological assessment, ed. 3. Oxford University Press, Oxford, 1995.
Nakamura H., Nakanishi M., Furukawa T., Hamanaka T., Tokudome S.: Validity of brief intelligence tests for patients with Alzheimer’s disease. Psychiatr. Clin. Neurosci. 54: 435–439, 2000.
Heaton R., Marcotte T.: Clinical neuropsychological tests and assessment techniques. In: Boller F., Grafman J., Rizzolatti G. (Eds.), Handbook of Neuropsychology, ed. 2. Elsevier, Amsterdam, 2000, pp. 27–52.
Kaplan E., Fein D., Moris R., Delis D.: The WAIS R as a neuropsychological instrument. The Psychological Corporation, San Antonio, TX, 1991.
Mercer W., Harrell E., Miller D., Childs H., Rockers D., Deldotto J.: Performance of healthy adults versus individuals with brain injuries on the supplemental measures of the WAIS-R NI. Brain Inj. 12: 753–758, 1998.
Devanand D., Folz M., Gorlyn M., Moeller J., Stern Y.: Questionable dementia: clinical course and predictors of outcome. J. Am. Geriatr. Soc. 45: 321–328, 1997.
Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R.: CAMDEX: A standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149: 698–709, 1986.
van Hout H., Teunisse S., Derix M., Poels P., Kuin Y., Vernooij- Dassen M., Grol R., Hoefnagels W.: CAMDEX, can it be more efficient? Observational study on the contribution of four screening measures to the diagnosis of dementia by a memory clinic team. Int. J. Geriatr. Psychiatry 16: 64–69, 2001.
Morris J.C., Mohs R.C., Rogers H., Fillenbaum G., Heyman A.: Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Clinical and neuropsychological assessment of Alzheimer’s disease. Psychopharmacol. Bull. 24: 641–652, 1988.
Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C.: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39: 1159–1165, 1989.
Welsh K.A., Butters N., Hughes J.P., Mohs R.C., Heyman A.: Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch. Neurol. 48: 278–281, 1991.
Tariot P., Mack J., Patterson M.: The CERAD Behavior Rating Scale for Dementia (BRSD). Am. J. Psychiatry 2001 (in press).
Mirra S.: Neuropathological assessment of Alzheimer’s disease: the experience of the Consortium to Establish a Registry for Alzheimer’s Disease. Int. Psychogeriatr. 9: 263–268, 1997.
Rosen W., Mohs R., Davis K.: A new rating scale for Alzheimer’s disease. Am. J. Psychiatry 141: 1356–1364, 1984.
Pena-Casanova J.: Alzheimer’s Disease Assessment Scale— Cognitive in clinical practice. Int. Psychogeriatr. 9 (Suppl. 1): 105–114, 1997.
Callahan C.M., Hendrie H.C., Tierney W.M.: Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann. Intern. Med. 122: 422–429, 1995.
Marcopulos B., Gripshover D., Broshek D., McLain C., Brashear H.: Neuropsychological assessment of psychogeriatric patients with limited education. Clin. Neuropsychol. 13: 147–156, 1999.
Eyler Zorrilla L., Heaton R., McAdams L., Zisook S., Harris M., Jeste D.: Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am. J. Psychiatr. 157: 1324–1326, 2000.
Paul R.H., Cohen R.A., Moser D., Ott B.R., Zawacki T., Gordon N., Bell S., Stone W.: Performance on the Mattis Dementia Rating Scale in patients with vascular dementia: relationships to neuroimaging findings. J. Geriatr. Psychiatr. Neurol. 14: 33–36, 2001.
Suarez S., Stankoff B., Conquy L., Rosenblum O., Seilhean D., Arvanitakis Z., Lazarini F., Bricaire F., Lubetzki C., Hauw J.J., Dubois B.: Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia. Eur. J. Neurol. 7: 151–158, 2000.
Vitaliano P.P., Breen A.R., Albert M.S., Russo J., Prinz P.N.: Memory, attention, and functional status in community- residing Alzheimer type dementia patients and optimally healthy aged individuals. J. Gerontol. 39: 58–64, 1984.
Mungas D., Marshall S., Weldon M., Haan M., Reed B.R.: Age and education correction of Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology 46: 700–706, 1996.
Salmon D.P., Kwo-on-Yuen P.F., Heindel W.C., Butters N, Thal L.J.: Differentiation of Alzheimer’s disease and Huntington’s disease with the Dementia Rating Scale. Arch. Neurol. 46: 1204–1208, 1989.
Brandt J., Spencer M., McSorley P., Folstein M.F.: Semantic activation and implicit memory in Alzheimer’s disease. Alzheimer Dis. Assoc. Disord. 2: 112–119, 1988.
Beatty W., Goodkin D.: Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch. Neurol. 47: 297–301, 1990.
Mahieux F., Michelet D., Manifacier M.-J., Boller F., Fermanian J., Guillard A.: Mini-Mental Parkinson: First validation study of a new bedside test constructed for Parkinson’s disease. Behav. Neurol. 8: 15–22, 1995.
Blessed G., Tomlinson B.E., Roth M.: The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114: 797–811, 1968.
Pfeiffer E.: Short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23: 433–441, 1975.
Reisberg B.: Functional Assessment Staging (FAST). Psychopharmacol. Bull. 24: 653–659, 1988.
Solomon P., Hirshoff A., Kelly B., Relin M., Brush M., De- Veaux R.D., Pendlebury W.W.: A 7 Minute Neurocognitive Screening Battery highly sensitive to Alzheimer’s disease. Arch. Neurol. 55: 349–355, 1998.
Verny M., Hugonot-Diener L., Boller F.: Severe dementia and its evaluation: scales for cognition, behavior and overall functioning. In: Boller F., Cappa S. (Eds.), Handbook of neuropsychology. Elsevier, Amsterdam, 2001, Vol. 6 (in press).
Ritchie K., Ledesert B.: The measurement of incapacity in the severely demented elderly: the validation of a behavioural assessment scale. Int. J. Geriatr. Psychiatry 6: 217–226, 1991.
Benesch C.G., McDaniel K.D., Cox C., Hamill R.W.: Endstage Alzheimer’s disease. Glasgow coma scale and the neurologic examination. Arch. Neurol. 50: 1309–1315, 1993.
Panisset M., Saxton J., Boller F.: End-stage Alzheimer’s disease: Glasgow Coma Scale and the neurologic examination. Arch. Neurol. 52: 127–128, 1995.
Cole M., Dastoor D.: The hierarchic dementia scale. J. Clin. Exp. Gerontol. 5: 219–234, 1983.
Peavy G., Salmon D., Rice V., Galasko D., Samuel W., Taylor K.I., Ernesto C., Butters N., Thal L.: Neuropsychological assessment of severely demented elderly. Arch. Neurol. 53: 367–372, 1996.
Saxton J., McGonigle-Gibson K., Swihart A., Miller M., Boller F.: Assessment of the severely impaired patient: description and validation of a new neuropsychological Test Battery. Psychological Assessment. J. Consult. Clin. Psychol. 2: 298–303, 1990.
Panisset M., Poncet M., Boller F., Simonetto J.: Validation de l’échelle CERAD. Premières données françaises. Paper presented at the 2nd francophone AD symposium, Marseille, eOctober 1993.
Verny M., Hugonot-Diener L., Saillon A.: Evaluation de la démence sévère: Echelles cognitives et comportementales (Groupe de Travail du Greco). Année Gérontologique 13: 156–168, 1999.
Pippi M., Mecocci P., Saxton J., Bartorelli L., Pettenati C., Bonaiuto S., Cucinotta D., Masaraki G., Neri M., Tammaro A.E., Vergani C, Chionne F., Senin U.: Neuropsychological assessment of the severely impaired elderly patient: validation of the Italian short version of the Severe Impairment Battery (SIB). Gruppo di Studio sull’Invecchiamento Cerebrale della Società Italiana di Gerontologia e Geriatria. Aging Clin. Exp. Res. 11: 221–226, 1999.
Llinas Regla J., Lozano Gallego M., Lopez O., Gudayol Portabella M., Lopez-Pousa S., Vilalta Franch J., Saxton J.: Validacion de la version española de la Severe Impairment Battery. Neurologia 10: 14–18, 1995.
Baddeley A.D., Hitch G.: Working Memory. In: Bower G. (Ed.), The psychology of learning and motivation: Advances in research and theory. Academic Press, New York, 1974, Vol. 8.
Baddeley A.: Working memory: The interface between memory and cognition. In: Schacter D.L, Tulving E. (Eds.), Memory Systems 1994. The MIT Press, Cambridge, MA, 1994.
Buschke H., Hinrichs J.V.: Controlled rehearsal and recall order in serial list retention. J. Exp. Psychol. 78: 502–509, 1968.
Wilson R.S., Bacon L.D., Fox J.H., Kaszniak A.W.: Primary memory and secondary memory in dementia of the Alzheimer’s type. J. Clin. Neuropsychol. 5: 337–344, 1983.
Belleville S., Peretz I., Malenfant D.: Examination of the working memory components in normal aging and in dementia of the Alzheimer type. Neuropsychologia 34: 195–207, 1996.
Morris R.G.: Dementia and the functioning of Articulatory Loop System. Cognitive Neuropsych. 1: 143–157, 1984.
Cherry B.J., Buckwalter J.G., Henderson V.W.: Memory span procedures in Alzheimer’s disease. Neuropsychol. 10: 286–293, 1996.
Kopelman M.D.: Rates of forgetting in Alzheimer-type dementia and Korsakoff’s syndrome. Neuropsychologia 23: 623–638, 1985.
Grossi D., Becker J.T., Smith C., Trojano L.: Memory for visuospatial patterns in Alzheimer’s disease. Psychol. Med. 23: 65–70, 1993.
Orsini A., Trojano L., Chiacchio L., Grossi D.: Immediate memory spans in dementia. Percept. Mot. Skills 67: 267–272, 1988.
Spinnler H., Della Sala S., Bandera R., Baddeley A.: Dementia, ageing, and the structure of human memory. Cognitive Neuropsych. 5: 193–211, 1988.
Baddeley A.D., Bressi S., Della Sala S., Logie R., Spinnler H.: The decline of Working Memory in Alzheimer’s disease. Brain 114: 2521–2542, 1991.
Spinnler H.: Alzheimer’s disease: neuropsychological defects according to topographical spreading of neuronal degeneration. In: Denes G., Pizzamiglio L. (Eds.), Handbook of clinical and experimental neuropsychology. Psychol. Press, Hove, 1999, pp. 699–746.
Poppelreuter W.: Die Psychichen Schadigungen durch Kopfschuss im Kriege 1914/16. L. Voss, Leipzig, 1917.
Stroop J.R.: Studies of interference in serial verbal reactions. J. Exp. Psychol. 18: 643–662, 1935.
Corsi P.M.: Interhemispheric differences in the localization of psychological processes in man. Unpublished doctoral dissertation. Quoted by Milner B., Br. Med. Bull. 27: 272, 1972.
Reitan R.M.: Validity of the Trail Making Test as an indication of the organic damage. Percept. Mot. Skills 8: 271–276, 1958.
Ramage A., Holland A.: Language in normal aging and age-related neurological disorders. In: Boller F., Grafman J. (Eds.), Handbook of neuropsychology. Elsevier, Amsterdam, 2001, Vol. 6 (in press).
Fuld P., Katzman R., Davies P., Terry R.: Intrusions as a sign of Alzheimer’s disease. Ann. Neurol. 11: 155–159, 1982.
Lukatela K., Malloy P., Jenkins M., Cohen R.: The naming deficit in early Alzheimer’s and vascular dementia. Neuropsychol. 12: 565–572, 1998.
Kaplan E., Goodglass H., Weintraub S.: Boston Naming Test. Experimental Edition, 1976.
Saxton J., Ratcliff G., Munro C.A., Coffey E.C., Becker J.T., Fried L., Kuller L.: Normative data on the Boston naming test and two equivalent 30-item short forms. Clin. Neuropsychol. 14: 526–534, 2000.
De Renzi E., Vignolo L.: The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain 85: 665–678, 1962.
Boller F., Vignolo A.L.: Latent sensory aphasia in hemisphere damaged patients: An experimental study with the Token Test. Brain 89: 815–830, 1966.
De Renzi E., Ferrari C.: The Reporter’s test: a sensitive test to detect disturbances in aphasics. Cortex 14: 279–293, 1978.
Lam L., Tang W., Leung V., Chiu H.: Behavioral profile of Alzheimer’s disease in Chinese elderly — a validation study of the Chinese version of the Alzheimer’s disease behavioral pathology rating scale. Int. J. Geriatr. Psychiatr. 16: 368–373, 2001.
Ripich D., Carpente B., Ziol E.: Comparison of African- American and white persons with Alzheimer’s disease on language measures. Neurology 48: 781–783, 1997.
Pasquier F., Grymonprez L., Lebert F., Van Der Linden M.: Memory impairment differs in frontotemporal dementia and Alzheimer’s disease. Neurocase 7: 161–171, 2001.
Holland A., Boller F., Bourgeois M.: Repetition in Alzheimer’s disease: A longitudinal study. J. Neurolinguistics 2: 163–177, 1986.
Holland A.: Communicative abilities in daily living. PROED, Austin TX, 1980.
Fromm D., Holland A.: Functional communication in Alzheimer’s disease. J. Speech Hear. Disord. 54: 535–540, 1989.
Tulving E.: Episodic and semantic memory. In: Tulving E., Donaldson W. (Eds.), Organization of memory. Academic Press, New York, 1972.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M.: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944, 1984.
Buschke H., Sliwinski M.J., Kuslansky G., Lipton R.B.: Diagnosis of early dementia by the double memory test: encoding specificity improves diagnostic sensitivity and specificity. Neurology 48: 989–997, 1997.
Jacobs D.M., Sano M., Dooneief G., Marder K., Bell K.L., Stern Y.: Neuropsychological detection and characterization of preclinical Alzheimer’s disease. Neurology 45: 957–962, 1995.
Masur D.M., Sliwinski M., Lipton R.B., Blau A.D., Crystal H.A.: Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44: 1427–1432, 1994.
Petersen R.C., Smith G.E., Ivnik R.J., Kokmen E., Tangalos E.G.: Memory function in very early Alzheimer’s disease. Neurology 44: 867–872, 1994.
Bondi M.W., Monsch A.U., Galasko D., Butters N., Salmon D.P., Delis D.C.: Preclinical cognitive markers of dementia of the Alzheimer’s type. Neuropsychology 8: 374–384, 1994.
Linn R.T., Wolf P.A., Bachman D.L., Knoefel J.E., Cobb J.L., Belanger A.J., Kaplan E.F., D’Agostino R.B.: The ’preclinical phase’ of probable Alzheimer’s disease: A 13- year prospective study of the Framingham cohort. Arch. Neurol. 52: 485–490, 1995.
Albert M.S.: Cognitive and neurobiological markers of early Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 93: 13547–13551, 1996.
Buschke H., Kuslansky G., Katz M., Stewart W.F., Sliwinski M.J., Eckholdt H.M., Lipton R.B.: Screening for dementia with the memory impairment screen. Neurology 52: 231–238, 1999.
Tulving E., Thomson D.M.: Encoding specificity and the retrieval processes in episodic memory. Psychol. Rev. 80: 352, 1973.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed. 3 revised. American Psychiatric Association, Washington, DC, 1987.
Buschke H.: Cued recall in amnesia. J. Clin. Neuropsychol. 6: 433–440, 1984.
Grober E., Buschke H., Crystal H., Dresner R.: Screening for dementia by memory testing. Neurology 38: 900–903, 1998.
Wechsler D.: Wechsler memory scale-revised manual. The Psychological Corporation, San Antonio, TX, 1987.
De Renzi E., Lucchelli F.: Ideational apraxia. Brain 111: 1173–1185, 1988.
Lucchelli F., Lopez O.L., Faglioni P., Boller F.: Ideomotor and ideational apraxia in Alzheimer’s disease. Int. J. Geriatr. Psychiatry 8: 413–417, 1993.
Mann U.M., Mohr E., Gearing M., Chase T.N.: Heterogeneity in Alzheimer’s disease — Progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J. Neurol. Neurosurg. Psychiatr. 55: 956–959, 1992.
Waldemar G., Bruhn P., Schmidt E., Kristensen M., Lassen N.A., Paulson O.B.: Cognitive profiles and regional cerebral blood flow patterns in dementia of the Alzheimer type. Eur. J. Neurol. 1: 81–89, 1994.
Weintraub S., Mesulam M.M.: Four neuropsychological profiles in dementia. In: Boller F., Grafman J. (Eds.), Handbook of neuropsychology, Vol 8. Elsevier, Amsterdam, 1993, pp. 253–282.
Boller F., Holland A., Forbes M., Hood P., McGonigle-Gibson K., Becker J.T.: Predictors of decline in Alzheimer’s disease. Neurology 40: 448, 1990.
Hebert M., Parlato V., Lese G.B., Dabaj A., Forette F., Boller F.: Survival in institutionalized patients: Influence of dementia and loss of functional capacities. Arch. Neurol. 52: 469–476, 1995.
Kaszniak A.W., Fox J., Gandell D.L., Garron D.C., Huckman N.A., Ramsey R.G.: Predictors of mortality in presenile and senile dementia. Ann. Neurol. 3: 246–252, 1978.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boller, F., Barba, G.D. Neuropsychological tests in Alzheimer’s disease. Aging Clin Exp Res 13, 210–220 (2001). https://doi.org/10.1007/BF03351479
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351479